Interferon Alfa-2B
This recombinant interferon protein boosts the immune system's natural antiviral and anticancer defenses. It has been used to treat chronic hepatitis B and C, hairy cell leukemia, melanoma, follicular lymphoma, and other conditions. Common side effects include fatigue, fever, and depression, and monitoring is required during treatment.
Molekularmasse
746,5000 g/mol
TPSA
113,00 Ų
Therapeutische Bereiche
Wirkmechanismus
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
2D-Struktur
Cite this structure
Embed this structure
SMILES
CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2.C(S(=O)(=O)[O-])(I)I.[Na+]
InChI
InChI=1S/C15H16Cl3N3O2.CH2I2O3S.Na/c1-2-4-20(15(22)21-5-3-19-10-21)6-7-23-14-12(17)8-11(16)9-13(14)18;2-1(3)7(4,5)6;/h3,5,8-10H,2,4,6-7H2,1H3;1H,(H,4,5,6);/q;;+1/p-1
Molecular Formula
C16H17Cl3I2N3NaO5S
HBD / HBA
- / 6
Rotierbare Bindungen
7
Schwere Atome
31
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
This recombinant interferon protein boosts the immune system's natural antiviral and anticancer defenses. It has been used to treat chronic hepatitis B and C, hairy cell leukemia, melanoma, follicular lymphoma, and other conditions. Common side effects include fatigue, fever, and depression, and monitoring is required during treatment.
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
Yes, Interferon Alfa-2B is an approved drug. It has reached clinical phase 4. It is classified as a Protein.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201558. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 71306834. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="interferon-alfa-2b"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/interferon-alfa-2b/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/interferon-alfa-2b/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/interferon-alfa-2b/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="interferon-alfa-2b"></drugfyi-drug>